In order to view this virtual session, you must be logged in.
If you haven't registered for this event, please register here first.
When to use antiplatelets, anticoagulants or both
Antiplatelet agents remain the mainstay for prophylaxis of arterial thrombosis, whilst anticoagulants are much more efficacious for venous and cardiac thromboembolism
Combining aspirin with low-dose rivaroxaban confers added benefit in patients with stable coronary and peripheral arterial disease
Combined antiplatelet and anticoagulant therapy may be indicated in patients with combined clinical indications, but the added antithrombotic benefit has to be weighed against the increased bleeding risk, especially in patients with high risk of bleeding
After this session, the next one will start at 13:00
professor of cardiovascular clinical pharmacology, King’s College London / Guy’s & St Thomas’ Hospitals
Albert Ferro studied Medicine at King’s College London (1978-1984), obtaining a 1st Class Honours intercalated BSc degree in Biochemistry in 1981 along the way. After qualifying, and following training as a junior doctor in medicine, he did his PhD in Clinical Pharmacology at Cambridge University. Since that time, his research and clinical interest have both focussed on the prevention and treatment of heart disease. He has been a Consultant Physician at Guy’s and St Thomas’ Hospitals in London since 1996, and was appointed Professor of Cardiovascular Clinical Pharmacology at King’s College London in 2009. He runs a hypertension clinic at Guy’s and St Thomas’, and has published over 150 papers in peer-reviewed journals. @AlbertF001